Mimedx (MDXG) Invested Capital (2010 - 2026)

Mimedx has disclosed Invested Capital across 15 years of filings, most recently posting $233.2 million for Q2 2026.

• In Q2 2026, Invested Capital fell 0.8% year-over-year to $233.2 million; the TTM figure through Jun 2026 stood at $233.2 million (down 0.8% YoY), while the FY2025 annual figure was $274.5 million, up 2.11% from the prior year.
• Invested Capital came in at $233.2 million for Q2 2026 at Mimedx, down from $260.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $274.5 million in Q4 2025 to a low of $30.6 million in Q4 2022.
• Average Invested Capital over 5 years is $183.7 million, with a median of $216.7 million recorded in 2024.
• The largest YoY upside for Invested Capital was 526.73% in 2023 against a maximum downside of 86.95% in 2023.
• Over 5 years, Invested Capital stood at $30.6 million in 2022, then soared by 526.73% to $191.8 million in 2023, then grew by 10.49% to $211.9 million in 2024, then increased by 29.53% to $274.5 million in 2025, then fell by 15.05% to $233.2 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $233.2 million in Q2 2026, $260.5 million in Q1 2026, and $274.5 million in Q4 2025.